Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes”, Funding Opportunity Announcement (FOA) IP08-001 and “Influenza Vaccine Efficacy in Tropical and Developing Countries”, FOA IP08-002

---
identifier: "/us/fr/E8-4754"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes”, Funding Opportunity Announcement (FOA) IP08-001 and “Influenza Vaccine Efficacy in Tropical and Developing Countries”, FOA IP08-002"
title_number: 0
title_name: "Federal Register"
section_number: "E8-4754"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes”, Funding Opportunity Announcement (FOA) IP08-001 and “Influenza Vaccine Efficacy in Tropical and Developing Countries”, FOA IP08-002"
positive_law: false
currency: "2008-03-10"
last_updated: "2008-03-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-4754"
document_type: "notice"
publication_date: "2008-03-10"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "73 FR 12740"
fr_volume: 73
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes”, Funding Opportunity Announcement (FOA) IP08-001 and “Influenza Vaccine Efficacy in Tropical and Developing Countries”, FOA IP08-002

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 9 a.m.-5 p.m., April 30, 2008 (Closed).

*Place:* Centers for Disease Control and Prevention, Atlanta, GA.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes”, Funding Opportunity Announcement (FOA) IP08-001 and “Influenza Vaccine Efficacy in Tropical and Developing Countries”, FOA IP08-002.”

*For Further Information Contact:* Christine J. Morrison, Ph.D., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-3098.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: February 29, 2008.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.